Pharmacists and pharmaceutical scientists must take responsibility for mitigating the environmental consequences of medicines, the International Pharmaceutical Federation (FIP) says.
The Food and Drug Administration (FDA) and the generic drug manufacturing industry —including representatives of generic pharmaceutical manufacturers, active pharmaceutical ingredient manufacturers and contract manufacturing organizations — have reached agreement on a package of program enhancements and resource commitments to reauthorize the Generic Drug User Fee Amendments of 2012 (GDUFA), which are set to expire next year.
Universities, professional organisations and authorities around the world have been enabled to take steps towards ensuring that pharmacists are capable and competent thanks to resources produced by FIP Education (FIPEd), the International Pharmaceutical Federation (FIP) has found.
Online Continuing Education Prepares Practitioners to Advance Safety of Medication Use Process
National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued the following statement in response to the J.D. Power 2016 U.S. Pharmacy Study released today